StockWatch
·

SAMRAT PHARMACHEM LTD.-$ Q2 FY26 Results

SAMRATPHQ2 FY26 Results
Filing
MetricValue ( Cr)Q1 FY26Q2 FY25
Revenue78.874.3%12.4%
Total Income78.923.4%11.7%
Expenditure79.674.6%18.6%
PBT-0.75460.1%121.3%
Net Profit-0.59156.6%122.1%
OPM-0.46%0.62pp4.30pp
NPM-0.74%0.44pp4.51pp
EPS1.90156.8%77.9%
View full financials

Informational and educational content only. Not investment advice.